The DOI matches its Crossref record; 104 of the 104 references it cites were found in a registry or an index.
New concepts in antimalarial use and mode of action in dermatology
Open accessAbstract
Although chloroquine, hydroxychloroquine and quinacrine were originally developed for the treatment of malaria, these medications have been used to treat skin disease for over 50 years. Recent clinical data have confirmed the usefulness of these medications for the treatment of lupus erythematosus. Current research has further enhanced our understanding of the pharmacologic mechanisms of action of these drugs involving inhibition of endosomal toll-like receptor (TLR) signaling limiting B cell and dendritic cell activation. With this understanding, the use of these medications in dermatology is broadening. This article highlights the different antimalarials used within dermatology through their pharmacologic properties and mechanism of action, as well as indicating their clinical uses. In addition, contraindications, adverse effects, and possible drug interactions of antimalarials are reviewed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Arzneimittelforschung: Erstanwendung am Menschen in der Phase I
Miletzki, B., & Gleiter, C. H. (2005) · Bundesgesundheitsblatt Gesundheitsforsch.Gesundheitsschutz · doi:10.1007/s00103-005-1024-7 · Cited by 9,355
Takeda, K., Kaisho, T., & Akira, S. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141126 · Cited by 6,143
The pharmacological basis of therapeutics
Frank, A. L. (1981) · Environmental Research · doi:10.1016/0013-9351(81)90176-6 · Cited by 2,734
Ohkuma, S., & Poole, B. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.7.3327 · Cited by 2,174
De Duve, C., De Barsy, T., Poole, B., Trouet, A., Tulkens, P., & Van Hoof, F. (1974) · Biochemical Pharmacology · doi:10.1016/0006-2952(74)90174-9 · Cited by 1,901
Chromatin–IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors
Leadbetter, E. A., Rifkin, I. R., Hohlbaum, A. M., Beaudette, B. C., Shlomchik, M. J., & Marshak-Rothstein, A. (2002) · Nature · doi:10.1038/416603a · Cited by 1,900
Human lupus autoantibody–DNA complexes activate DCs through cooperation of CD32 and TLR9
Means, T. K., Latz, E., Hayashi, F., Murali, M. R., Golenbock, D. T., & Luster, A. D. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200523025 · Cited by 849
Lau, C. M., Broughton, C., Tabor, A. S., Akira, S., Flavell, R. A., Mamula, M. J., Christensen, S. R., Shlomchik, M. J., Viglianti, G. A., Rifkin, I. R., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050630 · Cited by 812
CAPTURE AND PROCESSING OF EXOGENOUS ANTIGENS FOR PRESENTATION ON MHC MOLECULES
Watts, C. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.821 · Cited by 763
Gonzalez-Noriega, A., Grubb, J. H., Talkad, V, & Sly, W. S. (1980) · The Journal of cell biology · doi:10.1083/jcb.85.3.839 · Cited by 736
(1991) · New England Journal of Medicine · doi:10.1056/nejm199101173240303 · Cited by 677
Wallace, D. J. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-109-5-436_2 · Cited by 658
New insights into the antiviral effects of chloroquine
Savarino, A., Di Trani, L., Donatelli, I., Cauda, R., & Cassone, A. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70361-9 · Cited by 570
Ziegler, H. K., & Unanue, E. R. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.1.175 · Cited by 570
Distinctive cutaneous subsets in the spectrum of lupus erythematosus
Gilliam, J. N., & Sontheimer, R. D. (1981) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(81)80261-7 · Cited by 533
Hydroxychloroquine in lupus pregnancy
Clowse, M. E. B., Magder, L., Witter, F., & Petri, M. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22159 · Cited by 529
Alarcón, G. S., McGwin, G., Bertoli, A. M., Fessler, B. J., Calvo-Alén, J., Bastian, H. M., Vilá, L. M., & Reveille, J. D. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.068676 · Cited by 528
Sotelo, J., Briceño, E., & López-González, M. A. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-5-200603070-00008 · Cited by 505
Transfer of drugs and other chemicals into human milk
Roberts, R., Blumer, J. L., Gorman, R. L., Lambert, G. H., Rumack, B. H., SNODGRASS, W. T., Bennett, D. R., ', J. C., Petricciani, J. C., Licata, S., et al. (1989) · PEDIATRICS · Cited by 503
Effect of antimalarials on thrombosis and survival in patients with systemic lupus erythematosus
Ruiz-Irastorza, G., Egurbide, M.-V., Pijoan, J.-I., Garmendia, M., Villar, I., Martinez-Berriotxoa, A., Erdozain, J.-G., & Aguirre, C. (2006) · Lupus · doi:10.1177/0961203306071872 · Cited by 411
Eosinophilic fasciitis: Clinical spectrum and therapeutic response in 52 cases
Lakhanpal, S., Ginsburg, W. W., Michet, C. J., Doyle, J. A., & Moore, S. B. (1988) · Seminars in Arthritis and Rheumatism · doi:10.1016/0049-0172(88)90008-x · Cited by 410
Hydroxychloroquine (HCQ) in lupus pregnancy: double-blind and placebo-controlled study
Levy, R. A., Vilela, V. S., Cataldo, M. J., Ramos, R. C., Duarte, J. L., Tura, B. R., Albuquerque, E. M., & Jesús, N. R. (2001) · Lupus · doi:10.1191/096120301678646137 · Cited by 398
Brentano, F., Schorr, O., Gay, R. E., Gay, S., & Kyburz, D. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21273 · Cited by 377
Fessler, B. J., Alarcón, G. S., McGwin, G., Roseman, J., Bastian, H. M., Friedman, A. W., Baethge, B. A., Vilá, L., Reveille, J. D., & for the LUMINA Study Group (2005) · Arthritis & Rheumatism · doi:10.1002/art.21039 · Cited by 377
Recommendations on screening for chloroquine and hydroxychloroquine retinopathy
Marmor, M. F., Carr, R. E., Easterbrook, M., Farjo, A. A., & Mieler, W. F. (2002) · Ophthalmology · doi:10.1016/s0161-6420(02)01168-5 · Cited by 371
TREATMENT OF LUPUS ERYTHEMATOSUS WITH MEPACRINE
Page, F. (1951) · The Lancet · doi:10.1016/s0140-6736(51)91643-1 · Cited by 317
Costedoat‐Chalumeau, N., Amoura, Z., Duhaut, P., Huong, D. L. T., Sebbough, D., Wechsler, B., Vauthier, D., Denjoy, I., Lupoglazoff, J., & Piette, J. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11304 · Cited by 314
Costedoat‐Chalumeau, N., Amoura, Z., Hulot, J., Hammoud, H. A., Aymard, G., Cacoub, P., Francès, C., Wechsler, B., Huong, D. L. T., Ghillani, P., et al. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22156 · Cited by 309
Pharmacokinetics of Quinine, Chloroquine and Amodiaquine: Clinical Implications
Krishna, S., & White, N. J. (1996) · Clinical Pharmacokinetics · doi:10.2165/00003088-199630040-00002 · Cited by 304
Drug-Induced Skin Pigmentation
Dereure, O. (2001) · American Journal of Clinical Dermatology · doi:10.2165/00128071-200102040-00006 · Cited by 296
A Long-Term Study of Hydroxychloroquine Withdrawal on Exacerbations in Systemic Lupus Erythematosus
The Canadian Hydroxychloroquine Study Group, Tsakonas, E., Joseph, L., Esdaile, J. M., Choquette, D., Senécal, J.-L., Cividino, A., Danoff, D., Osterland, C. K., Yeadon, C., et al. (1998) · Lupus · doi:10.1191/096120398678919778 · Cited by 293
Clinical Pharmacokinetics and Metabolism of Chloroquine: Focus on Recent Advancements
Ducharme, J., & Farinotti, R. (1996) · Clinical Pharmacokinetics · doi:10.2165/00003088-199631040-00003 · Cited by 289
Lysosomal Sequestration of Amine-Containing Drugs: Analysis and Therapeutic Implications
Kaufmann, A. M., & Krise, J. P. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20792 · Cited by 284
van den Borne, B. E. E. M., Dijkmans, B. A. C., de ROOY, H. H., le Cessie, S., & Verweij, C. (1997) · PubMed · Cited by 281
Macfarlane, D. E., & Manzel, L. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.3.1122 · Cited by 261
The incidence of irreversible retinal toxicity in patients treated with hydroxychloroquine
Mavrikakis, I., Sfikakis, P. P., Mavrikakis, E., Rougas, K., Nikolaou, A., Kostopoulos, C., & Mavrikakis, M. (2003) · Ophthalmology · doi:10.1016/s0161-6420(03)00409-3 · Cited by 256
Levy, G. D., Munz, S. J., Paschal, J., Cohen, H. B., Pince, K. J., & Peterson, T. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400817 · Cited by 250
Hydroxychloroquine concentration–response relationships in patients with rheumatoid arthritis
Munster, T., Gibbs, J. P., Shen, D., Baethge, B. A., Botstein, G. R., Caldwell, J., Dietz, F., Ettlinger, R., Golden, H. E., Lindsley, H., et al. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10307 · Cited by 249
Comprehensive Dermatologic Drug Therapy
Hsu, S. (2002) · Archives of Dermatology · doi:10.1001/archderm.138.5.703 · Cited by 236
Wallace, D. J., Metzger, A. L., Stecher, V. J., Turnbull, B. A., & Kern, P. A. (1990) · The American Journal of Medicine · doi:10.1016/0002-9343(90)90345-e · Cited by 230
Chloroquine enhances human CD8 + T cell responses against soluble antigens in vivo
Accapezzato, D., Visco, V., Francavilla, V., Molette, C., Donato, T., Paroli, M., Mondelli, M. U., Doria, M., Torrisi, M. R., & Barnaba, V. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20051106 · Cited by 217
Projean, D., Baune, B., Farinotti, R., Flinois, J.-P., Beaune, P., Taburet, A.-M., & Ducharme, J. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.6.748 · Cited by 185
Thrombosis and Systemic Lupus Erythematosus: The Hopkins Lupus Cohort Perspective
Petri, M. (1996) · Scandinavian Journal of Rheumatology · doi:10.3109/03009749609069986 · Cited by 176
Acetaminophen Toxicity in Children
(2001) · PEDIATRICS · doi:10.1542/peds.108.4.1020 · Cited by 176
Antimalarial drugs in the treatment of rheumatological diseases.
Rynes, R. I. (1997) · Rheumatology · doi:10.1093/rheumatology/36.7.799 · Cited by 167
Wozniacka, A., Lesiak, A., Narbutt, J., McCauliffe, D. P., & Sysa-Jedrzejowska, A. (2006) · Lupus · doi:10.1191/0961203306lu2299oa · Cited by 158
Follow-Up of Infants Exposed to Hydroxychloroquine Given to Mothers during Pregnancy and Lactation
Motta, M., Tincani, A., Faden, D., Zinzini, E., Lojacono, A., Marchesi, A., Frassi, M., Rebaioli, C. B., Zatti, S., & Chirico, G. (2004) · Journal of Perinatology · doi:10.1038/sj.jp.7211208 · Cited by 155
Should clearance be normalised to body surface or to lean body mass?
Hallynck, T., Soep, H. H., Thomis, J. A., Boelaert, J. R., Daneels, R. F., & Dettli, L. (1981) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1981.tb01163.x · Cited by 155
Antimalarial agents: Closing the gate on toll‐like receptors?
Lafyatis, R., York, M. R., & Marshak‐Rothstein, A. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22157 · Cited by 153
Cytochrome P450 2C8 and CYP3A4/5 are involved in chloroquine metabolism in human liver microsomes
Kim, K., Park, J. Y., Lee, J., & Lim, S. (2003) · Archives of Pharmacal Research · doi:10.1007/bf02976712 · Cited by 152
Treatment of Disseminated Granuloma Annulare with Oral Vitamin E: ‘Primum Nil Nocere'
Poppe, H., Poppe, L. M., Goebeler, M., & Trautmann, A. (2013) · Dermatology · doi:10.1159/000353528 · Cited by 149
(1989) · PubMed · Cited by 147
Smoking interferes with efficacy of antimalarial therapy in cutaneous lupus.
Rahman, P., Gladman, D. D., & Urowitz, M. B. (1998) · PubMed · Cited by 145
Kyburz, D., Brentano, F., & Gay, S. (2006) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0292 · Cited by 136
Multifocal Electroretinographic Evaluation of Long-term HydroxychloroquineUsers
Maturi, R. K. (2004) · Archives of Ophthalmology · doi:10.1001/archopht.122.7.973 · Cited by 133
Pelle, M. T., & Callen, J. P. (2002) · Archives of Dermatology · doi:10.1001/archderm.138.9.1231 · Cited by 131
Weber, S. M., & Levitz, S. M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.3.1534 · Cited by 129
Does hydroxychloroquine sulfate prevent clot formation in systemic lupus erythematosus?
Wallace, D. J. (1987) · Arthritis & Rheumatism · doi:10.1002/art.1780301219 · Cited by 124 · cited 1×
“Chloroquine inhibits platelet aggregation and adhesion in a clinically relevant manner (70) .”
BackgroundChloroquine inhibits proinflammatory cytokine release into human whole blood
Karres, I., Kremer, J.-P., Dietl, I., Steckholzer, U., Jochum, M., & Ertel, W. (1998) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1998.274.4.r1058 · Cited by 124
Nowell, J., & Quaranta, V. (1985) · The Journal of Experimental Medicine · doi:10.1084/jem.162.4.1371 · Cited by 123
Pregnancy Outcome Following First Trimester Exposure to Chloroquine
Levy, M., Buskila, D., Gladman, D. D., Urowitz, M. B., & Koren, G. (1991) · American Journal of Perinatology · doi:10.1055/s-2007-999371 · Cited by 120
Merrill, J. T., & Lahita, R. G. (1996) · Lupus · doi:10.1177/096120339600500103 · Cited by 118
Evidence of transplacental passage of hydroxychloroquine in humans
Costedoat-Chalumeau, N., Amoura, Z., Aymard, G., Huong, D. U. L. T., Wechsler, B., Vauthier-Brouzes, D., Dermer, M. E., Darbois, Y., & Pietté, J. C. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10150 · Cited by 116
Multifocal Electroretinographic Changes in Patients Receiving Hydroxychloroquine Therapy
Lai, T. Y. Y., Chan, W., Li, H., Lai, R. Y. K., & Lam, D. S. C. (2005) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2005.05.046 · Cited by 115
Chloroquine stimulates nitric oxide synthesis in murine, porcine, and human endothelial cells.
Ghigo, D., Aldieri, E., Todde, R., Costamagna, C., Garbarino, G. M., Pescarmona, G., & Bosìa, A. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1052 · Cited by 113
Acetaminophen Toxicity in Children
Haun, S. E., & Segeleon, J. E. (2002) · PEDIATRICS · doi:10.1542/peds.110.1.197 · Cited by 111
Influence of hydroxychloroquine on the bioavailability of oral metoprolol
Somer, M., Kallio, J., Pesonen, U., Pyykkö, K. A., Huupponen, R., & Scheinin, M. (2000) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2000.00197.x · Cited by 109
The dominant self and the cryptic self: shaping the autoreactive T-cell repertoire
Gammon, G. M., Sercarz, E. E., & Bénichou, G. (1991) · Immunology Today · doi:10.1016/0167-5699(91)90052-u · Cited by 106
Koranda, F. C. (1981) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(81)70065-3 · Cited by 100
Discontinuation of antimalarial drugs in systemic lupus erythematosus.
Wang, C., Fortin, P. R., Li, Y., Panaritis, T., Gans, M., & Esdaile, J. M. (1999) · PubMed · Cited by 96
Reversal of MRP-mediated doxorubicin resistance with quinoline-based drugs.
Vezmar, M., & Georges, E. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00270-7 · Cited by 95
Cosnes, A., Amaudric, F., Gherardi, R., Verroust, J., Wechsler, J., Revuz, J., & Roujeau, J. C. (1995) · Archives of Dermatology · doi:10.1001/archderm.131.12.1381 · Cited by 92
Hydroxychloroquine Therapy in Massive Total Doses Without Retinal Toxicity
Johnson, M. W., & Vine, A. K. (1987) · American Journal of Ophthalmology · doi:10.1016/0002-9394(87)90005-5 · Cited by 92
Feldmann, R., Salomon, D., & Saurat, J. ‐. (2009) · Dermatology · doi:10.1159/000246899 · Cited by 89
The use of hydroxychloroquine in lupus pregnancy: the British experience
Khamashta, M. A., BUCHANAN, N., & Hughes, G. (1996) · Lupus · doi:10.1177/0961203396005001141 · Cited by 86
Dj, W. (1996) · PubMed · Cited by 82
Löffler, B., Bohn, E., Hesse, B., & Kunze, H. (1985) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(85)90114-6 · Cited by 78
Controlled therapeutic trials in polymorphic light eruption
Corbett, M., HAWK, J. L. M., Herxheimer, A., & Magnus, I. A. (1982) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1982.tb00409.x · Cited by 74
Antimalarial drugs for rheumatoid arthritis
Mackenzie, A. H. (1983) · The American Journal of Medicine · doi:10.1016/0002-9343(83)90474-6 · Cited by 73
Antimalarials—the ‘real‘ advance in lupus
Wallace, D. J. (2001) · Lupus · doi:10.1191/096120301678646092 · Cited by 72
Smith, G. D., Amos, T. A. S., Mahler, R., et al. (1987) · BMJ · doi:10.1136/bmj.294.6570.465 · Cited by 72
Inhibition of Mitogen-Activated Protein Kinase Signaling by Chloroquine
Weber, S. M., Chen, J., & Levitz, S. M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.10.5303 · Cited by 71
Management of Thrombosis in the Antiphospholipid Syndrome
Khamashta, M. A. (1996) · Lupus · doi:10.1177/096120339600500527 · Cited by 71
Antimalarials in cutaneous lupus erythematosus: mechanisms of therapeutic benefit
Woźniacka, A. J., Carter, A., & McCauliffe, D. P. (2002) · Lupus · doi:10.1191/0961203302lu147rr · Cited by 70
Beek, M. J. V., & Piette, W. W. (2001) · Dermatologic Clinics · doi:10.1016/s0733-8635(05)70236-9 · Cited by 69
Will some day PAPS fade into SLE?
Cabral, A., & Alarcón-Segovia, D. (1996) · Lupus · doi:10.1177/096120339600500102 · Cited by 67
Heart rate variability and cardiac autonomic function in systemic lupus erythematosus
Laganà, B., Tubani, L., Maffeo, N., Vella, C., Makk, E., Baratta, L., & Bonomo, L. (1996) · Lupus · doi:10.1177/096120339600500110 · Cited by 62
Woźniacka, A. J., Cygankiewicz, I., Chudzik, M., Sysa‐Jędrzejowska, A., & Wranicz, J. K. (2006) · Lupus · doi:10.1191/0961203306lu2345oa · Cited by 57
Management of Cutaneous Dermatomyositis: Current Therapeutic Options
Quain, R. D., & Werth, V. P. (2006) · American Journal of Clinical Dermatology · doi:10.2165/00128071-200607060-00002 · Cited by 52
Marmor, M. F. (2003) · Arthritis & Rheumatism · doi:10.1002/art.10980 · Cited by 45
Hydroxychloroquine potentiates Fas-mediated apoptosis of rheumatoid synoviocytes
Kim, W.-U., Yoo, S.-A., Min, S.-Y., Park, S.-H., Koh, H.-S., Song, S.-W., & Cho, C.-S. (2006) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2006.03070.x · Cited by 45
Pharmacogenetics of disease-modifying anti-rheumatic drugs
Tanaka, E., Taniguchi, A., Urano, W., Yamanaka, H., & Kamatani, N. (2004) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2004.02.006 · Cited by 44
Toubi, E., Kessel, A., Rosner, I., Rozenbaum, M., Paran, D., & Shoenfeld, Y. (2006) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2006.01737.x · Cited by 41
Antimalarial Drugs: Mechanisms of Action in Autoimmune Disease and Prospects for Drug Development
Fox, R. I. (1995) · BioDrugs · doi:10.1007/bf03259287 · Cited by 41
The Impact of Stereoisomerism in Bioequivalence Studies
Midha, K. K., McKay, G., Rawson, M. J., & Hubbard, J. W. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js9703683 · Cited by 36
McChesney, E. W., & Fitch, C. D. (1984) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-69254-3_1 · Cited by 31
Ct, J. (1985) · PubMed · Cited by 30
Pathogenetic mechanisms and treatment of cutaneous lupus erythematosus
Werth, V. P., Dutz, J. P., & Sontheimer, R. D. (1997) · Current Opinion in Rheumatology · doi:10.1097/00002281-199709000-00005 · Cited by 26
Self-citationHepatotoxicity associated with the use of a fixed combination of chloroquine and proguanil
Wielgo-Polanin, R., Lagarce, L., Gautron, E., Diquet, B., & Lainé‐Cessac, P. (2005) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2005.04.019 · Cited by 23
Glucose-6-phosphate dehydrogenase deficiency: Mechanisms of drug-induced hemolysis
Hochstein, P. (1971) · Experimental Eye Research · doi:10.1016/s0014-4835(71)80051-9 · Cited by 19
Stuhlmeier, K. M., & Pollaschek, C. (2006) · PubMed · Cited by 15
Intrapleural quinacrine instillation for recurrent pneumothorax or persistent air leak
Janzing, H. M. J., Derom, A., Derom, E., Eeckhout, C., Derom, F. E., & Rosseel, M. (1993) · The Annals of Thoracic Surgery · doi:10.1016/0003-4975(93)90999-x · Cited by 13
The role of anti-malarials in rheumatoid arthritis – the American experience
Khraishi, M. M., & Singh, G. (1996) · Lupus · doi:10.1177/0961203396005001101 · Cited by 13
Haehner, T., Refaie, M. O. I., & Müller‐Enoch, D. (2011) · Arzneimittelforschung · doi:10.1055/s-0031-1296940 · Cited by 11
Cited by
Jamilloux, Y., Henry, T., Belot, A., Viel, S., Fauter, M., El Jammal, T., Walzer, T., François, B., & Sève, P. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102567 · Cited by 658
Hydroxychloroquine: From Malaria to Autoimmunity
Ben-Zvi, I., Kivity, S., Langevitz, P., & Shoenfeld, Y. (2012) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-010-8243-x · Cited by 613
Al-Bari, M. A. A. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv018 · Cited by 467
Therapeutic Targeting of Toll-Like Receptors for Infectious and Inflammatory Diseases and Cancer
O’Neill, L. A. J., Bryant, C. E., & Doyle, S. L. (2009) · Pharmacological Reviews · doi:10.1124/pr.109.001073 · Cited by 427
Plantone, D., & Koudriavtseva, T. (2018) · Clinical Drug Investigation · doi:10.1007/s40261-018-0656-y · Cited by 305
Metadata
- Authors
- Kalia, S., & Dutz, J. P.
- Venue
- Dermatologic Therapy
- Publisher
- Hindawi Limited
- Published
- 2007-07
- Volume
- 20
- Issue
- 4
- Pages
- 160-174
- ISSN
- 1396-0296 (ISSN-L)
- 1529-8019
- OpenAlex
- W1985390439
- Cited by
- 257
- References
- 104
- FWCI
- 9.31
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.